ICPT - Intercept Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Intercept Pharmaceuticals's activity chart (see below) currently has 518 price targets and 432 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 31.37% of the time, taking 77.95 days on average.

Our record on Intercept Pharmaceuticals covers 38 analysts since 2008. Of the 365 price targets those analysts set on ICPT, 108 were reached (30%). The latest calls: Edward Nash of Canaccord cut the target to $19 from $20 with a Buy rating on 27 Sep 2023; Mayank Mamtani of B. Riley raised the target to $19 from $15 with a Buy rating on 27 Sep 2023; Ed Arce of Westpark kept the target at $19 with a Buy rating on 27 Sep 2023. Figures as of 18 Nov 2026.

Most recent stock forecast was given by from CANACCORD on 27-Sep-2023. First documented stock forecast 13-Aug-2013.

Best performing analysts who are covering ICPT - Intercept Pharmaceuticals:

Alethia Young Brian Skorney Navin Jacob Ritu Baral Andrew Berens

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 03-Aug-2023

$19

$20

3 years 1 months 23 days ago
(27-Sep-2023)

2/8 (25%)

$0.42 (2.26%)

86

Buy Since 12-Jan-2022

$19

$15

3 years 1 months 23 days ago
(27-Sep-2023)

3/16 (18.75%)

$0.42 (2.26%)

57

Buy Since 03-Aug-2023

$19

$19

3 years 1 months 23 days ago
(27-Sep-2023)

11/14 (78.57%)

$0.42 (2.26%)

66

Hold Since 10-Nov-2020

$19

$13

3 years 1 months 23 days ago
(27-Sep-2023)

12/25 (48%)

$0.42 (2.26%)

39

Buy Since 10-Nov-2020

$19

$18

3 years 1 months 24 days ago
(26-Sep-2023)

6/27 (22.22%)

$0.29 (1.55%)

66

Show more analysts

Please expand the browser size to see the chart

What is ICPT (Intercept Pharmaceuticals) average time for price targets to be met?

On average it took 78 days for the stock forecasts to be reached, with an average price target met ratio of 31.37%.

Which analyst most recently updated their price target on ICPT (Intercept Pharmaceuticals)?

Which analyst has the most public recommendations on ICPT (Intercept Pharmaceuticals)?

has 0 price targets and 0 ratings on ICPT

Which analyst is the currently most bullish on ICPT (Intercept Pharmaceuticals)?

Matthew Roden with the highest potential upside of $446

Which analyst is the currently most reserved on ICPT (Intercept Pharmaceuticals)?

Salveen Richter with the lowest potential downside of -$7
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?